Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lü, Malcolm V. Brock, Richard J. Battafarano et al.|Nature|2020Cited by 339
Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacineRita de Cássia Collaço, Frank Bosmans, Maxime Lammens et al.|Clinical Autonomic Research|2023Cited by 9
A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant OnesWei Liu, Yuping Mei, Yuyan Wang et al.|Non-Coding RNA|2021Cited by 9
A TRIzol-based method for high recovery of plasma sncRNAs approximately 30 to 60 nucleotidesKristen Rodgers, Yuping Mei, Alicia Hulbert et al.|Scientific Reports|2022Cited by 8
PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapyAndrei Gurau, Yuping Mei, Suguru Yamauchi et al.|Non-coding RNA Research|2025Cited by 4